Androgen replacement therapy with dehydroepiandrosterone for androgen insufficiency and female sexual dysfunction: Androgen and questionnaire results

Journal of Sex and Marital Therapy

Volumn 28, Issue , 2002, Pages 165-173

  Munarriz, Ricardo ^a,d   Talakoub, Lily ^a   Flaherty, Elizabeth ^a   Gioia, Melissa ^a   Hoag, Lisa ^a   Kim, Noel N ^a   Traish, Abdulmaged ^a   Goldstein, Irwin ^a   Guay, André ^b   Spark, Richard ^c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d Department of Urology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE;

ACNE; ADULT; ANDROGEN INSUFFICIENCY; ARTICLE; BLOOD FLOW; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; EVALUATION; FEMALE; FEMALE SEXUAL DYSFUNCTION; HAIR GROWTH; HAIR LOSS; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; LUBRICATION; MAJOR CLINICAL STUDY; MASTALGIA; ORGASM; QUESTIONNAIRE; RASH; RETROSPECTIVE STUDY; SATISFACTION; SEXUAL AROUSAL; SIDE EFFECT; SYNDROME; WEIGHT GAIN;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANDROGENS; DEHYDROEPIANDROSTERONE; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 0036193210     PISSN: 0092623X     EISSN: 15210715     Source Type: Journal    
DOI: 10.1080/00926230252851285     Document Type: Article

References (7)

1. Abraham, G. E. (1974). Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. Journal of Clinical Endocrinology and Metabolism, 39, 340–346.
2. Barrett-Connor, E., Friedlander, N. J., & Khaw, K. T. (1990). Dehydropiandrosterone sulfate and breast cancer risk. Cancer Research, 50, 6571–6574.
3. Davis, S. R. (1999). Androgen replacement in women: A commentary. Journal of Clinical Endocrinology and Metabolism, 84, 1886–1891.
4. Derogatis, L. R. (2000). Female sexual distress scale (FSDS): Preliminary report. Presented at the 2000 Female Sexual Function Forum, Boston, MA.
5. Laumann, E. O., Paik, A.,& Rosen, R. C. (1999). Sexual dysfunction in the United States. Prevalence and predictors. Journal of the American Medical Association, 281, 537–544.
6. Mazer, N., (2000). New clinical applications of transdermal testosterone delivery in men and women. Journal of Controlled Release, 65, 303–315.
7. Rosen, R., Brown, C., Heiman, J., Leiblum, S., Menton, C., Shabsigh, R., Ferguson, D., & D’Agartino, R. Jr. (2000). The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. Journal of Sex & Marital Therapy, 26, 191–208.